INOVIQ Limited (EGQ0)
XSTU
Real-time Data
06:00 AM
Day's Range
0.109052 wk Range
0.1020Overview - EGQ0 - INOVIQ Limited
Key Statistics
Valuation
Enterprise Value
-787.31K
P/E (Trailing)
‪-1.34‬
Price / Sales (TTM)
‪5.62‬
Price / Book
‪0.86‬
EV / EBITDA
‪0.20‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-369.99%‬
Return on Assets
‪-20.74%‬
Return on Equity
‪-34.66%‬
Ownership
Shares Outstanding
105.51M
Float
115.93M
Held by Insiders
‪33.95%‬
Held by Institutions
‪7.00%‬
Price stats
Beta
‪1.55‬
50-Day Avg
‪0.1447‬
200-Day Avg
‪0.1761‬
Dividends
Payout Ratio
‪0.00%‬
Peers - EGQ0 - INOVIQ Limited
Peer Comparison
Compared with companies in Diagnostics & Research listed on XSTU.
- EGQ0XSTUINOVIQ Limited15.48MMarket Cap-81.82%52-week change-1.77P/E (Trailing)‪0.00%‬Profit Margin
- NL0XSTUGrail, Inc.3.09BMarket Cap+58.79%52-week change-6.25P/E (Trailing)‪-236.94%‬Profit Margin
- 1K9XSTUCareDx Inc.947.04MMarket Cap+72.93%52-week change-101.50P/E (Trailing)‪67.55%‬Profit Margin
- LMQXSTUOxford Biodynamics Plc978.78KMarket Cap-150.00%52-week change-0.13P/E (Trailing)‪47.67%‬Profit Margin
Profile Summary - EGQ0 - INOVIQ Limited
About
INOVIQ Limited is a biotechnology company specializing in the development and commercialization of advanced diagnostic and exosome-based products, primarily aimed at improving early detection, monitoring, and treatment outcomes in oncology. Its innovative platforms encompass proprietary technologies such as EXO-NET®…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
